ALXO Stock Analysis: Buy, Sell, or Hold?
ALXO - ALX Oncology Holdings Inc. Common Stock
$1.97
-0.16 (-7.29%)
▼
5d:
-10.05%
30d:
+34.93%
90d:
+15.88%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
28d
Get Alerted When ALXO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ALXO is down 10.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ALXO is down 10.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALXO is currently trading at $1.97, which is considered slightly high relative to its 30-day fair value range of $1.52 to $2.11.
Technical Outlook: Technically, ALXO is in a strong uptrend. The price is currently testing key support at $1.94. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: ALXO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.60 (+133.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALXO is in a strong uptrend. The price is currently testing key support at $1.94. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: ALXO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.60 (+133.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.52 -
$2.11
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.7%
Protect Your Profits
Holding ALXO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.3%)
- BULLISH: Trading 133.5% below Wall St target ($4.60)
- WARNING: Recommendation downgraded due to -10.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.52 -
$2.11
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.94
Resistance Level
$2.41
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.66
Wall Street Target
$4.60
(+133.5%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 13, 2026 6:01 PM ET
Data refreshes hourly during market hours. Next update: 7:01 PM
Data refreshes hourly during market hours. Next update: 7:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALXO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Jason Lettmann
SELL
12311 shares
2026-03-19
Shelly Pinto
SELL
903 shares
2026-03-19
Corey S Goodman
BUY
3184713 shares
2026-02-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$441 | 60 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 62 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 67 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 61 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 59 HOLD |
Advanced ALXO Option Strategies
Professional options setups generated by AI based on today's ALXO price and gamma walls.
